Lehman Ronald G.
Transaction: 06/03/2026
OTHER
Change
0
Price
Not reported
Filing
06/09/2026
Type
OTHER
FONAR Corporation
FONR • Medical - Devices
$19.09
— 0.00 (0.00%)
Current price
EarningsLatest report: Mar 31, 2026
BALANCED PROFILENeutralConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$120.19M
Growth
2.0%
Cash Flow
5/5
Trend
Stable
Evidence
Positive free cash flow · 1.18Consistent free cash flow · 5/5Reasonable earnings multiple · 11.34Manageable debt level · 0.23Healthy liquidity · 8.45
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 11, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$19.09
Change0.00%
Shares Out6.30M
Market Cap$120.19M
Enterprise Value$70.45M
52W Range13.62 - 19.16
Beta0.96
P/E17.97
P/S1.14
P/B0.67
P/FCF26.68
EV/Sales0.67
Price$19.09
Change0.00%
Shares Out6.30M
Market Cap$120.19M
Enterprise Value$70.45M
52W Range13.62 - 19.16
Beta0.96
P/E17.97
P/S1.14
P/B0.67
P/FCF26.68
EV/Sales0.67
EV/EBITDA5.02
EV/FCF15.64
Earnings Yield5.57%
FCF Yield3.75%
Dividend Yield0.00%
Gross Margin41.12%
Oper. Margin11.12%
Profit Margin7.99%
Debt/Eq0.23
Current Ratio8.45
Quick Ratio8.28
Revenue 5Y1.97%
Volume0.00
Avg Volume80.58K
Investment DNA
How strong this company looks for long-term investors
69
out of 100
Business Quality
Margins, moat, returns
49/100
Financial Strength
Debt, cash, stability
95/100
Growth Potential
Revenue and expansion
45/100
Price Attractiveness
Cheap or expensive today
92/100
Why this score▼
Positive free cash flow · 1.18Consistent free cash flow · 5/5Reasonable earnings multiple · 11.34Manageable debt level · 0.23Healthy liquidity · 8.45
Analyst view
No analyst data available now.
Insider Transactions
Recent executive and insider activity
Chan Claudette
Transaction: 06/23/2025
OTHER
Change
0
Price
Not reported
Filing
06/09/2026
Type
OTHER
Lehman Ronald G.
Transaction: 12/01/2020
BUY
Change
+2,629
Price
Not reported
Filing
06/09/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Lehman Ronald G. | OTHER | 0 | Not reported | 06/03/2026 | 06/09/2026 |
| Chan Claudette | OTHER | 0 | Not reported | 06/23/2025 | 06/09/2026 |
| Lehman Ronald G. | BUY | +2,629 | Not reported | 12/01/2020 | 06/09/2026 |
| Lehman Ronald G. | BUY | +488 | Not reported | 07/17/2019 | 06/09/2026 |
| Lehman Ronald G. | BUY | +363 | Not reported | 07/11/2018 | 06/09/2026 |
| Lehman Ronald G. | BUY | +350 | Not reported | 06/21/2017 | 06/09/2026 |
| Lehman Ronald G. | BUY | +500 | Not reported | 08/23/2016 | 06/09/2026 |
| Lehman Ronald G. | OTHER | 0 | Not reported | 04/23/2012 | 06/09/2026 |
| Chan Claudette | OTHER | 0 | Not reported | 10/15/1987 | 06/09/2026 |
| Damadian Timothy Raymond | OTHER | 0 | Not reported | 06/03/2026 | 06/08/2026 |
| Bonanni Luciano B | OTHER | 0 | Not reported | 06/03/2026 | 06/08/2026 |
| Turk Richard E. | OTHER | 0 | Not reported | 06/03/2026 | 06/08/2026 |
| Maher Jessica | OTHER | 0 | Not reported | 06/03/2026 | 06/08/2026 |
| Carrino Robert M. | OTHER | 0 | Not reported | 06/03/2026 | 06/08/2026 |
| Carrino Robert M. | OTHER | 0 | Not reported | 07/02/2025 | 06/08/2026 |
| Maher Jessica | OTHER | 0 | Not reported | 03/20/2023 | 06/08/2026 |
| Damadian Timothy Raymond | BUY | +36,359 | Not reported | 11/08/2022 | 06/08/2026 |
| Bonanni Luciano B | BUY | +8,066 | Not reported | 12/01/2020 | 06/08/2026 |
| Turk Richard E. | OTHER | 0 | Not reported | 06/04/2020 | 06/08/2026 |
| Bonanni Luciano B | BUY | +7,455 | Not reported | 07/10/2019 | 06/08/2026 |